
Christine Bestvina
Associate Professor of Medicine · University of Chicago Medical Center
Credentials: · · · · ·
History
- 2015–2017
- 2012–2015
Internal Medicine
Research
Patient-oncologist cost communication, financial distress, and medication adherence
Journal of Oncology Practice · 2014 · First of 13 authors · 225 citations
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors
Nature · 2024 · 178 citations
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC
Cancer Discovery · 2023 · 174 citations

24 papers

12 papers

11 papers

9 papers

9 papers

8 papers

7 papers

6 papers
Clinical trials
- 2022–2030
Principal investigator · Active not recruiting · Phase 2, Phase 3
National Cancer Institute (NCI)
- 2022–2027
Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)
Principal investigator · Recruiting · Phase 2
University of Chicago
- 2023–2027
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
- 2020–2027
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)


